Phase 2, clinical trial to evaluate LifeViroTreat inhalation in mild COVID patient.
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/07/035233
- Lead Sponsor
- Supreme Industries
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
1.RT-PCR positive for nCOVID-19 within last 72 hours
2.Male and female patients with age above 18 years and below 65 years of age.
3.Patient willing to provide informed consent to participate into the trial.
4.Patient able to comply requirement of study and protocol.
5.Patient having SpO2 > 94 %, Respiratory rate < 24/min and temperature < 104 �°F
1Known hypersensitivity or idiosyncratic reaction to Chlorine or any of related substance or ingredient of the formulation.
2Patient having past history of respiratory disorder like COPD, Asthma etc.
3Patient is on medication before tested nCOVID 19 positive for respiratory disease or disorder (other than viral infection).
4Patients who are diagnosed and/or on treatment for venous thromboembolism, ischemic heart disease, myocardial infarction, congestive cardiac failure, unexplained vaginal bleeding with suspicion of serious underlying condition, history of breast or cervical cancer, malignant tumor
5Patient of Hypertension and/or Diabetes who was not on stable treatment in past 3 month.
6Patient was on immunomodulatory drug
7Have participated in other clinical study related to nCOVID 19
8Patients with other severe acute or chronic conditions that may increase the risk of participation in the study and study treatment, or may interfere with interpretation of study results, and judged by the investigator as not suitable for participation in this clinical trial.
9Known history of Chronic Kidney disease
10Known history of Chronic Liver disease
11Nursing mother or pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method